Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Duearity

Mindre end 1K følgere
Alle
Analyse
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse10.3.2024, 12.43

Duearity has entered into an agreement with a national distributor in the USA

Duearity
Pressemeddelelse6.2.2024, 07.53

Clinics in the US can now purchase Tinearity G1 through a national trading platform

Duearity
Eminova Partners day - Duearity
Video15.1.2024, 11.34 af
Lucas Mattsson, Jesper Hagman

Eminova Partners day - Duearity

During the day with Eminova Partners, analyst Lucas Mattsson got the chance to interview Fredrik Westman, CEO of Duearity. The discussion includes Duearity as an investment, what the market looks like today and what the strategy for Duearity looks like in the future.

Duearity

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse20.12.2023, 07.50

Duearity's sales SEK 450,000 in December - the best month so far

Duearity
Selskabsmeddelelse2.10.2023, 09.11

Duearity AB has signed a distributor agreement - covering Belgium, the Netherlands and Luxembourg

Duearity
Pressemeddelelse25.8.2023, 08.29

Duearity Americas Inc has signed agreements with the first clinics in the United States

Duearity
Selskabsmeddelelse27.7.2023, 08.22

Duearity AB has signed a distributor agreement in Great Britain

Duearity
Pressemeddelelse5.6.2023, 06.00

Positive results from Duearity's user study on people with tinnitus

Duearity
Selskabsmeddelelse23.5.2023, 09.01

Duearity AB has signed a distributor agreement

Duearity
Selskabsmeddelelse26.4.2023, 12.52

The tinnitus product Tinearity G1 has received market approval in the UK

Duearity
Selskabsmeddelelse31.10.2022, 07.27

Duearity will submit an application for approval of a tinnitus product in the United States

Duearity
Selskabsmeddelelse2.11.2021, 07.41

Duearity to develop AI solution for people suffering from tinnitus

Duearity
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.